Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1

Abigail K. Suwala(German Cancer Research Center), Damian Stichel(German Cancer Research Center), Daniel Schrimpf(German Cancer Research Center), Sybren L. N. Maas(Utrecht University), Martin Sill(German Cancer Research Center), Hildegard Dohmen(Justus-Liebig-Universität Gießen), Rouzbeh Banan(Heidelberg University), Annekathrin Reinhardt(German Cancer Research Center), Philipp Sievers(German Cancer Research Center), Felix Hinz(German Cancer Research Center), Mirjam Blattner-Johnson(German Cancer Research Center), Christian Hartmann(Medizinische Hochschule Hannover), Leonille Schweizer(German Cancer Research Center), Henning B. Boldt(University of Southern Denmark), Bjarne Winther Kristensen(University of Copenhagen), Jens Schittenhelm(University Children's Hospital Tübingen), Matthew D. Wood(Oregon Health & Science University), Guillaume Chotard(Université de Bordeaux), Rolf Bjergvig(University of Bergen), Anirban Das(Hospital for Sick Children), Uri Tabori(University of Toronto), Martin Hasselblatt(University Hospital Münster), Andrey Korshunov(German Cancer Research Center), Zied Abdullaev(National Cancer Institute), Martha Quezado(National Cancer Institute), Kenneth Aldape(National Cancer Institute), Patrick N. Harter(Goethe University Frankfurt), Matija Snuderl(NYU Langone Health), Jürgen Hench(University Hospital of Basel), Stephan Frank(University Hospital of Basel), Till Acker(Justus-Liebig-Universität Gießen), Sebastian Brandner(Royal London Hospital), Frank Winkler(German Cancer Research Center), Pieter Wesseling(Princess Máxima Center), Stefan M. Pfister(German Cancer Research Center), David Reuß(German Cancer Research Center), Wolfgang Wick(German Cancer Research Center), Andreas von Deimling(German Cancer Research Center), David Jones(German Cancer Research Center), Felix Sahm(German Cancer Research Center)
Acta Neuropathologica
April 19, 2021
Cited by 55Open Access
Full Text

Abstract

Glioblastoma IDH-wildtype presents with a wide histological spectrum. Some features are so distinctive that they are considered as separate histological variants or patterns for the purpose of classification. However, these usually lack defined (epi-)genetic alterations or profiles correlating with this histology. Here, we describe a molecular subtype with overlap to the unique histological pattern of glioblastoma with primitive neuronal component. Our cohort consists of 63 IDH-wildtype glioblastomas that harbor a characteristic DNA methylation profile. Median age at diagnosis was 59.5 years. Copy-number variations and genetic sequencing revealed frequent alterations in TP53, RB1 and PTEN, with fewer gains of chromosome 7 and homozygous CDKN2A/B deletions than usually described for IDH-wildtype glioblastoma. Gains of chromosome 1 were detected in more than half of the cases. A poorly differentiated phenotype with frequent absence of GFAP expression, high proliferation index and strong staining for p53 and TTF1 often caused misleading histological classification as carcinoma metastasis or primitive neuroectodermal tumor. Clinically, many patients presented with leptomeningeal dissemination and spinal metastasis. Outcome was poor with a median overall survival of only 12 months. Overall, we describe a new molecular subtype of IDH-wildtype glioblastoma with a distinct histological appearance and genetic signature.


Related Papers

No related papers found

Powered by citation graph analysis